Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
589 Leser
Artikel bewerten:
(2)

M-DAQ Pte Ltd: Global investors to settle cross-currency equity trades in their currency of choice through Turquoise M-DAQ FX workflow

Finanznachrichten News
  • Turquoise and M-DAQ sign cooperation agreement, to work together to deliver multi-asset market efficiencies.
  • Turquoise M-DAQ will provide brokers with an innovative composite equity and FX trading workflow, with enriched data analytics in multiple currencies.
  • Turquoise M-DAQ participants will benefit from a single relationship, reduced operational risk, whilst providing global investors transparency, better outcomes and the true cost of their equity and FX transactions.

LONDON, Aug. 24, 2022 /PRNewswire/ -- M-DAQ, a leading global FX specialist, today announced its cooperation with Turquoise, the pan-European MTF majority owned by London Stock Exchange Group (LSEG). The collaboration envisions a new service to investors who, through their brokers, will be able to execute cross-currency securities transactions and settle in their currency of choice (subject to regulatory approval).

Turquoise M-DAQ will democratise FX in equity trading market by settling trades in an investor's currency of choice, allowing them to access foreign assets with more ease and confidence.

Turquoise is a multilateral trading facility (MTF) regulated by the UK FCA, also with the ability to accept members from overseas jurisdictions including Singapore, Hong Kong S.A.R. and Dubai amongst others. As an MTF, it provides global investors with access to order books to trade nearly 4300 securities (including ETFs, ADRs, GDRs) of 20 countries including from Europe, Switzerland, the UK and US - all through a single interface. With M-DAQ headquartered in Singapore, the combined workflow will enhance the foreign investment paradigm across continents.

Continuing its path to improve market structure through innovation, M-DAQ will contribute its patented product Trading the Right Chart (TRC). This complements well the capabilities of Turquoise, removing the need for multilateral relationships and reduces FX operational risk faced by brokers, delivering further efficiencies to equity capital markets and better outcomes for end investors.

Richard Koh, Founder & Group CEO of M-DAQ Global, said: "M-DAQ is delighted to be the first Singapore flagship fintech to partner with Turquoise. By leveraging our wealth of experience, we can offer customers the ability to efficiently execute small FX transactions fitting the securities order shapes and using our tried and tested technology capabilities. We are well positioned to work alongside Turquoise to bring the global equities market a solution that would allow cross-border investors to access foreign assets with more ease and confidence."

Dr. Robert Barnes, Group Head of Securities Trading, LSEG, & CEO Turquoise Global Holdings, said: "Turquoise is committed to serving our clients through innovation and partnership. Together, Turquoise M-DAQ will bring transparency, automation and efficiency to trading of securities that settle in an investor's currency of choice. I look forward to continuing our collaboration with M-DAQ to deliver benefits for brokers and investors."

About M-DAQ

Founded in 2010 with a vision to create a World without Currency Borders, M-DAQ is a Singapore-headquartered company that empowers businesses in various industries to facilitate cross-border transactions with its best-in-class FX solutions. M-DAQ has embarked on a global growth plan to capture market opportunities and to create a new fintech ecosystem, focusing on providing specialised technology-enabled financial services to enterprise customers and other downstream fintechs. Backed by global institutions such as Affinity Equity Partners, Ant Group, EDBI, NTT Communications and Samsung, M-DAQ has processed over S$32bn of cross-border transactions over 45 markets since the launch of its Aladdin FX solution in 2016. M-DAQ turned net profitable in 2018. This has enabled the Company to harness its technology to invest in new business lines while maintaining a strong balance sheet.

M-DAQ's technological solutions rely on the use of big data through its predictive engine and a proprietary algorithm supported by two-thirds of the world's foreign exchange liquidity providers. The business has also won multiple inaugural fintech and enterprise awards over the years.

Photo - https://mma.prnewswire.com/media/1883426/M_DAQ_Turquoise_Tile.jpg

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.